New combo therapy shows promise for breast cancer brain tumors in early trial
NCT ID NCT03807765
First seen Jan 05, 2026 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This early-phase study tested whether giving a type of focused radiation (stereotactic radiosurgery) right after an immunotherapy drug (nivolumab) is safe and helps control breast cancer that has spread to the brain. Fourteen adults with up to 10 brain tumors took part. The main goal was to check for serious side effects like brain swelling or seizures. Researchers also tracked whether the treated tumors shrank or stayed stable. The approach aims to improve treatment options for this hard-to-treat condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.